Alcohol Dependence Disrupted the Brain's Natural Cannabinoid System in the Amygdala

What the researchers found

Alcohol dependence decreased baseline 2-AG levels and increased glutamate and GABA in the central amygdala. Acute withdrawal intensified these changes. Re-exposure to alcohol restored 2-AG and GABA levels. MAGL inhibitors (which boost 2-AG) reduced both anxiety-like behavior and excessive alcohol consumption in dependent animals.

Why it matters

This study reveals that the endocannabinoid system in the amygdala - a key brain region for emotional processing - becomes dysregulated in alcohol dependence. This provides a biological mechanism for why alcohol-dependent individuals experience anxiety during withdrawal and drink excessively.

The numbers in context

Alcohol dependence decreased baseline 2-AG and increased glutamate and GABA. MAGL inhibitors MJN110 (10 and 20 mg/kg in rats) and JZL184 (1 and 3 mg/kg in mice) reduced anxiety and excessive drinking.

How the study worked

Rats and mice were made alcohol-dependent through chronic intermittent exposure. In vivo microdialysis measured endocannabinoid and amino acid levels in the central amygdala. Pharmacological studies tested the effects of endocannabinoid-boosting drugs on anxiety and alcohol consumption.

What this study cannot tell us

Animal study results may not translate directly to humans. The specific doses and administration routes are experimental. The central amygdala is one of many brain regions involved in addiction.

How to read the evidence

Moderate - multi-method approach combining microdialysis, pharmacology, and behavioral testing across two species, but all preclinical.

When this study was published

Published in 2018.

The bigger picture

The endocannabinoid system may be a common thread linking different substance use disorders. This study shows that alcohol dependence fundamentally alters endocannabinoid signaling in ways that promote continued use, suggesting that endocannabinoid-based therapies could treat multiple addictions.

Questions still open

• Could MAGL inhibitors treat alcohol use disorder in humans? Does cannabis use affect alcohol dependence through this same endocannabinoid mechanism? Are similar 2-AG deficits found in human alcoholics?

Common questions

Read the original research

Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 43(9), 1840-1850

Citation

Serrano, Antonia; Pavon, Francisco J; Buczynski, Matthew W; Schlosburg, Joel; Natividad, Luis A; Polis, Ilham Y; Stouffer, David G; Zorrilla, Eric P; Roberto, Marisa; Cravatt, Benjamin F; Martin-Fardon, Rémi; Rodriguez de Fonseca, Fernando; Parsons, Loren H. (2018). Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 43(9), 1840-1850. https://doi.org/10.1038/s41386-018-0055-3

Explore the wider topic

• Physical vs Psychological Cannabis Dependence: What Science Actually Shows
• The Gap Between Cannabis Perception and Science: Why What We Believe Outpaces What We Know
• Cannabis Use Disorder: Am I Addicted? Self-Assessment Guide
• Cross-Addiction After Quitting Weed: When One Habit Replaces Another
• Is Weed Addictive? What the Research Actually Shows
• Is Cannabis Addictive? What the DSM-5 and Brain Science Say
• Quitting Weed and Alcohol Together: What to Know About Dual Cessation
• Is Rehab Necessary for Weed? An Honest Assessment
• Signs You May Have Cannabis Use Disorder: An Honest Self-Assessment
• Weed Vape Pen Addiction: Why Vaping Makes It Harder to Quit